Spyre Therapeutics, Inc. (SYRE)
48.98
+1.40
(+2.94%)
USD |
NASDAQ |
Apr 06, 16:00
48.90
-0.08
(-0.16%)
After-Hours: 20:00
Spyre Therapeutics SG&A Expense (TTM) : 47.91M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 29.83M |
| Savara, Inc. | 42.06M |
| Agios Pharmaceuticals, Inc. | 180.28M |
| Tandem Diabetes Care, Inc. | 444.99M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |